FluMist Articles
Flu vaccine innovation needed to protect children, says GlobalData health care expert
13 January 2013
Trudeau Institute discovers how FluMist elicits protection
24 August 2011
Sharp rise in US FDA approvals of biopharmaceuticals in 2009, highest since 2005, says BII
18 January 2010
GlaxoSmithKline beats forecasts with 3rd quarter2009 profits leaping 34%, despite generic competition
28 October 2009
Merck & Co gets exclusive US rights to CSL’s Afluria season flu vaccine
29 September 2009
US FDA approves vaccines for 2009 H1N1 influenza virus
16 September 2009
FDA licenses Sanofi flu vaccine plant
8 May 2009
US seasonal flu vaccine ships early
1 September 2008
GSK to begin shipping flu shots to USA
18 August 2008
2008/9 flu vaccines approved by US FDA
11 August 2008
UPDATE: MedImmune's biologics capabilities to boost AstraZeneca's flagging pipeline
17 December 2007
Sanofi-Aventis to invest in China vaccines plant
3 December 2007
FDA c'ttee recommends expanded indication for FluMist
29 October 2007
FDA approves CSL Biotherapies' Aflurina
15 October 2007
FDA expands FluMist approval
8 October 2007
US FDA approves CSL's flu vacc, Alfuria
8 October 2007
MedImmune resolves FDA vacc plant concerns
17 September 2007
Drug Royalty buys FluMist royalties
16 July 2007
Novartis to increase Fluvirin production by 30%
9 July 2007
MedImmune's FluMist sBLA makes progress
4 June 2007
MedImmune's 1st-qtr profit triples on Synagis
21 May 2007
MedImmune willing to consider takeover
23 April 2007
Vaxefectin produces dose-sparing effect in animal study
16 April 2007
Positive data from trials of MedImmune's FluMist
2 April 2007
MedImmune's 4th-qtr income rises 7%
19 February 2007
US FDA clears fridge formula FluMist
15 January 2007
Sanofi Pasteur meets US flu vacc delivery target, promises more
4 December 2006
Stock Commentary - Europe - week to Nov 27
4 December 2006
GSK joins with USA's HHS and CDC to encourage flu vaccinations
20 November 2006
MedImmune's 3rd-qtr loss down 13% $55.8M
6 November 2006
Sanofi Pasteur makes first Fluzone shipments to USA
11 September 2006
Novartis ships first Fluvirin shots to USA
28 August 2006
MedImmune's 2nd-qtr 2006 loss deepens 43%
31 July 2006
GSK submits Flulaval BLA to US FDA
3 April 2006
US FDA guidance to expedite flu vaccs
20 March 2006
Sanofi Pasteur sees record demand for Fluzone flu vacc
13 February 2006
Chiron posts 12% sales jump on flu vacc return
13 February 2006
FFF to distribute GSK's Fluarix in USA
12 December 2005
Sanofi Pasteur to complete flu vaccine shipments early
12 December 2005
Stock Commentary - Europe - week to Sept 12
19 September 2005
GSK buys Wyeth vaccines plant
12 September 2005
Novartis bids $4.5B to buy rest of Chiron
5 September 2005
Sanofi-Pasteur starts on US flu vacc plant
1 August 2005
More vaccine making woes for Chiron
25 July 2005
MedImmune's new flu vacc performs well
27 June 2005
GSK files Fluarix BLA with US FDA
6 June 2005
New data on FluMist from MedImmune
23 May 2005
FDA clears Sanofi Pasteur's pediatric flu vaccine
14 March 2005
Chiron reveals status change in SEC inquiry
21 February 2005
MedImmune posts 15% rise in sales
14 February 2005
Chiron expects regulatory inspection of UK facility
17 January 2005
Chiron gets FDA warning letter
20 December 2004
GSK to start pivotal trial for Fluarix
20 December 2004
1.2M doses of GSK's Fluarix for USA, under IND
13 December 2004
UPDATE: GSK gets $28M US flu vaccine order
13 December 2004
US HHS Sec seeks to assure on flu vaccine
1 November 2004
3rd-qtr profit for Chiron despite Fluvirin woes
1 November 2004
MedImmune's 3rd-qtr loss grows four-fold
1 November 2004
MedImmune expands FluMist production
1 November 2004
FDA says Chiron vaccine "not safe for US market"
25 October 2004
Aventis Pasteur ships 30 million doses of Fluzone
11 October 2004
In August, biotech emerges from doldrums, but uncertainty persists: Burrill review
13 September 2004
MedImmune's 2nd-qtr plunges into loss
2 August 2004
Henry Schein to distribute MedImmune's FluMist
21 June 2004
Chiron to produce Avian flu vacc for NIH studies
31 May 2004
FTC clears MedImmune vaccine reqacquisition
31 May 2004
MedImmune plans for $2B sales in 2009
8 March 2004
Second FDA drug imports "blitz" finds 80% come from Canada
9 February 2004
New Chemical Entities in 2003
19 January 2004
Chiron boosts meningococcal vacc production for NZ
19 January 2004
US Medicare bill and biotech reimbursement
15 December 2003
FluMist wins Best of What's New award
17 November 2003
Wyeth's FluMist hitting US market
8 September 2003
Powderject loses out to Aventis on contract
11 August 2003
FDA OKs MedImmune and Wyeth's FluMist
30 June 2003
Stock Commentary - New York
30 June 2003
PowderJect invests L85M in vaccine facility
16 June 2003
Update: Chiron and PowderJect agree L542M merger
26 May 2003
Chiron and PowderJect agree L542M merger
26 May 2003
MedImmune a step closer to FluMist approval?
15 July 2002
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Pfizer to split-off remaining 80% interest in Zoetis
